APA (7th ed.) Citation

IG, S., MB, S., JM, F., M, P., Y, W., TS, B., . . . C, A. (2024). Lutetium-177 DOTATATE Therapy and Cardiac Outcomes in Patients With Neuroendocrine Tumor and Cardiac Metastases. JACC. CardioOncology, 6(6), 982. https://doi.org/10.1016/j.jaccao.2024.09.008

Chicago Style (17th ed.) Citation

IG, Scalia, et al. "Lutetium-177 DOTATATE Therapy And Cardiac Outcomes in Patients With Neuroendocrine Tumor and Cardiac Metastases." JACC. CardioOncology 6, no. 6 (2024): 982. https://doi.org/10.1016/j.jaccao.2024.09.008.

MLA (9th ed.) Citation

IG, Scalia, et al. "Lutetium-177 DOTATATE Therapy And Cardiac Outcomes in Patients With Neuroendocrine Tumor and Cardiac Metastases." JACC. CardioOncology, vol. 6, no. 6, 2024, p. 982, https://doi.org/10.1016/j.jaccao.2024.09.008.